Halberd CorpOTC Pink - Limited Information:HALB
- LAST PRICE0.0085
- TODAY'S CHANGE (%)0.0007 (8.9744%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0090 / 0.0078
- Day Range
- 52 Week Range
- Volume1,396,365
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | HALB |
|---|---|---|
| 09:32 ET | 100 | 0.009 |
| 09:50 ET | 6500 | 0.0085 |
| 10:29 ET | 20000 | 0.0084 |
| 10:31 ET | 20000 | 0.0084 |
| 10:33 ET | 250000 | 0.008 |
| 10:40 ET | 500 | 0.008 |
| 12:50 ET | 8091 | 0.008 |
| 01:33 ET | 241909 | 0.008 |
| 02:32 ET | 64345 | 0.008 |
| 02:56 ET | 200 | 0.0085 |
| 02:59 ET | 14900 | 0.008 |
| 03:01 ET | 500000 | 0.0078 |
| 03:35 ET | 117352 | 0.0085 |
| 03:46 ET | 82648 | 0.0085 |
| 03:53 ET | 69820 | 0.0085 |
Today
Jan 24, 2023
Halberd Agrees to Animal Testing at Mississippi State University, from 8:00AM ET on Tuesday Jan 24, 2023 by Accesswire
8:00AM ET on Tuesday Jan 24, 2023 by Accesswire
Jan 3, 2023
Halberd Corporation 2022 Year End CEO Letter and 2023 Goals, from 8:00AM ET on Tuesday Jan 03, 2023 by Accesswire
8:00AM ET on Tuesday Jan 03, 2023 by Accesswire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Halberd Corp | 4.0M | 3.7x | --- |
American Cryostem Corp | 4.2M | -1.5x | --- |
LadRx Corp | 3.9M | -0.3x | --- |
Altamira Therapeutics Ltd | 3.3M | -0.1x | --- |
Dermata Therapeutics Inc | 3.8M | -0.2x | --- |
GlobeStar Therapeutics Corp | 4.3M | -0.8x | --- |
Company Information
Halberd Corporation is a holding company. The Company is engaged in the acquisition vehicle for established businesses. It also is developing treatments for neurodegenerative diseases, such as post-traumatic stress disorder/chronic traumatic encephalopathy (PTSD/ CTE), Alzheimer’s disease and Parkinson’s disease. It is a patented extracorporeal treatment that is applicable to many hard-to-cure blood-borne and neurologic diseases, including Covid-19, other viruses and cancer. The Company’s wholly owned subsidiary is Alaric Corporation.
Contact Information
- Headquarters
- P.O. Box 25JACKSON CENTER, PA, United States 16133
- Phone
- ---
- Fax
- ---
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.0M |
|---|---|
Revenue (TTM) | $281.2K |
Shares Outstanding | 515.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -4.56 |
EPS | $0.00 |
Book Value | $0.00 |
P/E Ratio | 3.7x |
Price/Sales (TTM) | 14.3 |
Price/Cash Flow (TTM) | 158.6x |
Operating Margin | 34.12% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
